easyNOTES Medical
Endoscopic Treatment of Type 2 Diabetes
Company Overview
Snapshot
Founded in January 2011 by Moshe Mizrahi, easyNOTES Medical operates with 1–10 employees. The company is in the Pre-Funding stage, focusing on the development of medical devices. The company ceased operations in October 2022.
Business overview
easyNOTES Medical is a Health Tech & Life Sciences company specializing in the development, manufacture, and marketing of medical devices for the endoscopic treatment of Type 2 diabetes. Its core product, EasyByPass, is a non-surgical, endoscopic procedure designed to treat Type 2 diabetes with a low risk of complications, minimizing patient inconvenience and eliminating the need for hospitalization. The company targets the global healthcare market, serving clinics, hospitals, and healthcare providers with solutions for prevention and treatment in gastroenterology and diabetes.
Log in to access full profile ›Company Intelligence Q&A
- What is easyNOTES Medical's primary focus?
- easyNOTES Medical is focused on the development, manufacture, and marketing of medical devices for the endoscopic treatment of Type 2 diabetes.
- What is the key product offered by easyNOTES Medical?
- The company's key product is EasyByPass, a simple, non-surgical, endoscopic procedure designed for treating Type 2 diabetes.
- When was easyNOTES Medical founded?
- easyNOTES Medical was founded in January 2011.
- What is the operational status of easyNOTES Medical?
- easyNOTES Medical ceased to operate in October 2022.
- Who is a co-founder of easyNOTES Medical?
- Moshe Mizrahi is a co-founder and Chairman of easyNOTES Medical.